Harnessing the Natural Homing Capabilities of Stem Cells
NanoGhost is a pre‐clinical‐stage synthetic biology company engineering next‐generation cancer detection and treatment agents.
NanoGhost has developed a novel, versatile and highly selective targeted drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), cells with known tropism to cancer and sites of inflammation.
NanoGhosts can be loaded with various drug types, preserve MSCs tropism to cancer cells, and selectively penetrate tumors, leading to a major reduction in tumor size and prolonged survival.
NanoGhost’s proprietary engineering and manufacturing know‐how results in consistent, precise and efficient targeted delivery of therapeutics to sites of cancer and inflammation, with the potential to revolutionize current treatment modalities and survival.